Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

3.

Prognostic value of 6-minute walk test in stable outpatients with heart failure.

Arslan S, Erol MK, Gundogdu F, Sevimli S, Aksakal E, Senocak H, Alp N.

Tex Heart Inst J. 2007;34(2):166-9.

4.

[Differences in clinical profile and outcome in patients with decompensated heart failure and systolic dysfunction or preserved systolic function].

Macín SM, Perna ER, Címbaro Canella JP, Alvarenga P, Pantich R, Ríos N, Farías EF, Badaracco JR.

Rev Esp Cardiol. 2004 Jan;57(1):45-52. Spanish.

5.

Heart failure with preserved left ventricular ejection fraction in patients with acute myocardial infarction.

Antonelli L, Katz M, Bacal F, Makdisse MR, Correa AG, Pereira C, Franken M, Fava AN, Serrano Junior CV, Pesaro AE.

Arq Bras Cardiol. 2015 Aug;105(2):145-50. doi: 10.5935/abc.20150055. Epub 2015 May 29. English, Portuguese.

6.

Uric acid and gamma-glutamyl transferase activity are associated with left ventricular remodeling indices in patients with chronic heart failure.

Radovanovic S, Savic-Radojevic A, Pekmezovic T, Markovic O, Memon L, Jelic S, Simic D, Radic T, Pljesa-Ercegovac M, Simic T.

Rev Esp Cardiol (Engl Ed). 2014 Aug;67(8):632-42. doi: 10.1016/j.rec.2013.11.017. Epub 2014 Mar 29.

PMID:
25037542
7.

[Clinical characteristics and medium-term prognosis of patients with heart failure and preserved systolic function. Do they differ in systolic dysfunction?].

Ojeda S, Anguita M, Muñoz JF, Rodríguez MT, Mesa D, Franco M, Ureña I, Vallés F.

Rev Esp Cardiol. 2003 Nov;56(11):1050-6. Spanish.

8.
9.

Interaction between two predictors of functional outcome after revascularization in ischemic cardiomyopathy: left ventricular volume and amount of viable myocardium.

Mandegar MH, Yousefnia MA, Roshanali F, Rayatzadeh H, Alaeddini F.

J Thorac Cardiovasc Surg. 2008 Oct;136(4):930-6. doi: 10.1016/j.jtcvs.2007.11.061. Epub 2008 May 12.

10.

Left Ventricular Reverse Remodeling With Biventricular Versus Right Ventricular Pacing in Patients With Atrioventricular Block and Heart Failure in the BLOCK HF Trial.

St John Sutton M, Plappert T, Adamson PB, Li P, Christman SA, Chung ES, Curtis AB.

Circ Heart Fail. 2015 May;8(3):510-8. doi: 10.1161/CIRCHEARTFAILURE.114.001626. Epub 2015 Feb 19.

11.

Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. SOLVD Investigators.

Benedict CR, Shelton B, Johnstone DE, Francis G, Greenberg B, Konstam M, Probstfield JL, Yusuf S.

Circulation. 1996 Aug 15;94(4):690-7.

12.
13.

Elevated serum uric acid levels are associated with diastolic dysfunction in patients with dilated cardiomyopathy.

Cicoira M, Zanolla L, Rossi A, Golia G, Franceschini L, Brighetti G, Zeni P, Zardini P.

Am Heart J. 2002 Jun;143(6):1107-11.

PMID:
12075270
14.

[Serum copper levels in patients with chronic heart failure associated with systolic left ventricular dysfunction and its relation to the severity of cardiac failure].

Málek F, Spacek R, Polásek R, Karel L, Stanka P, Zenáhlíková M, Jiresová E.

Vnitr Lek. 2001 Nov;47(11):753-6. Czech.

PMID:
11795180
15.

Relation of serum uric acid levels and outcomes among patients hospitalized for worsening heart failure with reduced ejection fraction (from the efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan trial).

Vaduganathan M, Greene SJ, Ambrosy AP, Mentz RJ, Subacius HP, Chioncel O, Maggioni AP, Swedberg K, Zannad F, Konstam MA, Senni M, Givertz MM, Butler J, Gheorghiade M; EVEREST trial investigators.

Am J Cardiol. 2014 Dec 1;114(11):1713-21. doi: 10.1016/j.amjcard.2014.09.008. Epub 2014 Sep 16.

PMID:
25312638
16.

Reduced right ventricular ejection fraction as a marker for idiopathic dilated cardiomyopathy compared with ischemic left ventricular dysfunction.

La Vecchia L, Zanolla L, Varotto L, Bonanno C, Spadaro GL, Ometto R, Fontanelli A.

Am Heart J. 2001 Jul;142(1):181-9.

PMID:
11431676
17.

Independent determinants of the Tei index in hypertensive patients with preserved left ventricular systolic function.

Masugata H, Senda S, Goda F, Yamagami A, Okuyama H, Kohno T, Hosomi N, Yukiiri K, Noma T, Murao K, Nishiyama A, Kohno M.

Int Heart J. 2009 May;50(3):331-40.

18.
19.

Continuous-flow left ventricular assist device therapy in patients with preoperative hepatic failure: are we pushing the limits too far?

Weymann A, Patil NP, Sabashnikov A, Mohite PN, Garcia Saez D, Bireta C, Wahlers T, Karck M, Kallenbach K, Ruhparwar A, Fatullayev J, Amrani M, De Robertis F, Bahrami T, Popov AF, Simon AR.

Artif Organs. 2015 Apr;39(4):336-42. doi: 10.1111/aor.12375. Epub 2014 Oct 27.

PMID:
25345547
20.

The profile and prognosis of patients hospitalised with heart failure. The value of discharge blood pressure amd cholesterol.

Jindrich S, Ondrej L, Viktor M, Zbynek P, Tomas P, Ladislav D, Jiri V, Lenka S, Miroslav S.

Int Heart J. 2008 Nov;49(6):691-705.

Supplemental Content

Support Center